HomepageEarnings Events Newsdesk 4 days ago Bristol-Myers Squibb Company (BMY) nnounces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release Bruker Corp (BRKR) Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum » « Becton, Dickinson and Company (BDX) BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency Newsdesk: